Washington Administrative Code (Last Updated: November 23, 2016) |
Title 182. Health Care Authority |
Chapter 182-540. Kidney disease program and kidney center services. |
Section 182-540-001. Purpose. |
Section 182-540-005. Kidney disease program (KDP)—Definitions. |
Section 182-540-015. Kidney disease program (KDP)—General eligibility criteria. |
Section 182-540-021. Kidney disease program (KDP)—Household size. |
Section 182-540-022. Kidney disease program (KDP)—Income eligibility. |
Section 182-540-023. Kidney disease program (KDP)—Change of circumstances. |
Section 182-540-025. Kidney disease program (KDP)—Application and recertification requirements—KDP contractor. |
Section 182-540-026. Kidney disease program (KDP)—Application and recertification requirements—Client. |
Section 182-540-030. Kidney disease program (KDP)—Resource eligibility. |
Section 182-540-045. Kidney disease program (KDP) contractor requirements. |
Section 182-540-055. Kidney disease program (KDP) covered services. |
Section 182-540-060. Kidney disease program (KDP) client appeal rights. |
Section 182-540-065. Kidney disease program (KDP)—Reimbursement. |
Section 182-540-101. Purpose and scope. |
Section 182-540-105. Definitions. |
Section 182-540-110. Eligibility. |
Section 182-540-120. Provider requirements. |
Section 182-540-130. Covered services. |
Section 182-540-140. Noncovered services. |
Section 182-540-150. Reimbursement—General. |
Section 182-540-160. Items and services included in the composite rate. |
Section 182-540-170. Items and services not included in the composite rate. |
Section 182-540-180. Laboratory services. |
Section 182-540-190. Blood products and services. |
Section 182-540-200. Epoetin alpha (EPO) therapy. |
Section 182-540-210. Injectable drugs given in the kidney center. |